Cellular Immune Monitoring
Our peptide formats allow efficient profiling of target-specific cellular immune responses by cellular assays such as ELISPOT and Flow Cytometry. As successful immune monitoring has a huge impact on the success of clinical studies, JPT has developed unique peptide specifications that avoid peptide cross contamination, inhibit false positive T-cell stimulation by synthetic by-products, eliminate cell toxic by-products and allow for peptide stability monitoring, peptide solubility evaluation and more. For critical clinical trial monitoring JPT maintains a specification called ISO PLUS that complies with relevant regulatory requirements on line clearance, quality oversight, batch documentation and more. The combination of our long-term peptide chemistry and bioinformatics knowledge with highest regulated quality standards enables efficient, high quality clinical profiling of cellular immune responses.